Powder: -20°C for 3 years | In solvent: -80°C for 1 year
3-arylisoquinolinamine derivative is a compound with antitumor activity.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
2 mg | 約 5 days | ¥ 12,500 |
5 mg | 約 5 days | ¥ 27,500 |
1 mL * 10 mM (in DMSO) | 約 5 days | ¥ 24,500 |
ターゲット&IC50 | Colon HCT 116 cells:17 nM , MDA-MB-231 cells:21 nM , Pancreas PANC-1:19 nM , Kidney Caki-1:22 nM , OVCAR-3 (ovary):14 nM , SNB19 (Glioblastoma):32 nM , Prostate PC3:19 nM , SK-MEL-28 cells:32 nM |
In vivo | The 3-arylisoquinolinamine derivative demonstrates superior antitumor efficacy, achieving 69.2% inhibition of tumor growth in an animal model, outperforming the control drug, Paclitaxel, which exhibits 48.8% inhibition [2]. |
分子量 | 293.36 |
分子式 | C18H19N3O |
CAS No. | 1029008-71-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (170.44 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
3-arylisoquinolinamine derivative 1029008-71-6 Others 3 arylisoquinolinamine derivative 3arylisoquinolinamine derivative Inhibitor inhibitor inhibit